Atlantic Edge Private Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6K Buy
483
+238
+97% +$12.9K ﹤0.01% 342
2026
Q1
$15.4K Hold
245
﹤0.01% 347
2025
Q4
$23.4K Hold
245
0.01% 293
2025
Q3
$23.9K Hold
245
0.01% 290
2025
Q2
$26.3K Hold
245
0.01% 263
2025
Q1
$24.7K Hold
245
0.01% 260
2024
Q4
$21.9K Buy
245
+95
+63% +$8.36K 0.01% 266
2024
Q3
$12.6K Hold
150
﹤0.01% 315
2024
Q2
$11.6K Hold
150
﹤0.01% 301
2024
Q1
$10.3K Hold
150
﹤0.01% 312
2023
Q4
$8.67K Buy
+150
New +$8.01K ﹤0.01% 305

Other funds holding BSX

Atlantic Edge Private Wealth Management's BSX Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management increased its Boston Scientific (BSX) stake by 97% in Q2 2026, buying an estimated $12.9K and bringing the position to 483 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Atlantic Edge Private Wealth Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $26.3K in Q2 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Atlantic Edge Private Wealth Management held 483 shares of Boston Scientific worth $20.6K as of Q2 2026.
  • Atlantic Edge Private Wealth Management bought 238 Boston Scientific shares in Q2 2026, an estimated $12.9K.
  • Boston Scientific made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #342 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Atlantic Edge Private Wealth Management's Boston Scientific position peaked at $26.3K in Q2 2025.
  • 1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.